Press Release: Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Ca...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2544348533

Press Release: Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer

About this item

Full title

Press Release: Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer

Publisher

New York: Dow Jones & Company Inc

Journal title

Dow Jones Institutional News, 2021

Language

English

Formats

Newsletter articles

Publication information

Publisher

New York: Dow Jones & Company Inc

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Press Release: Immunicum Announces Enrollment of First Patient in Phase I ALISON Study Evaluating Cancer Relapse Vaccine Candidate DCP-001 in Ovarian Cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2544348533

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2544348533

How to access this item

Log in as a Library member

View record in ProQuest

View in old catalogue

Connecting people and collections

Indigenous engagement

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Learning

Resources and programs for school and university students, teachers, families and lifelong learners.

Stories

Showcasing people, places and ideas inspired by the collection and the library community.